BREAKTHROUGH: All 18 hospitalized individuals at the Ziv Medical Center in Safed that were administered Amor-18 from Amorphical, recovered in a phase II trial and were shortly discharged.
By ROSSELLA TERCATIN
All 18 COVID-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
The trial was conducted at the Ziv Medical Center in Safed and led by the directors of the coronavirus department, Dr. Continue Reading »
Instead of the meant ‘at-risk’ Palestinian population receiving intended doses, PA autocrat Mahmoud Abbas transferred 200 vaccine doses to Jordan and the PA “health ministry” reported 12,000 vaccine doses were allocated to PLO members and to Abbas’ security personnel.
By Elad Benari
The Palestinian Authority (PA) acknowledged on Tuesday that it has given COVID-19 vaccines to senior PA officials and to the Jordanian royal family, Kan News reported.
Kan News reported several weeks ago that the PA had transferred 200 vaccines to Jordan, but PA officials denied the report. On Tuesday, the PA “health ministry” confirmed that 200 vaccines were transferred to the office of Jordanian King Abdullah II. Continue Reading »
In order to secure the release of an Israeli woman who had been held by its longtime enemy, Syria, Israel agreed to purchase the Russian “Sputnik V” vaccine for Syrian healthcare workers, in an exchange deal brokered in Moscow.
Syria’s health minister said on Thursday it had received COVID-19 vaccination doses from a “friendly country” and healthcare workers would start receiving inoculations next week.
Hassan Ghabash’s comments, carried by state news agency SANA, did not specify which country provided the vaccines or how many doses had arrived.
Continue Reading »
Medical worker in Moscow holds the Sputnik V vaccine. – Photo: Mos.ru
Although the 30th patient also fully recovered later on, 29 out of 30 moderate-to-severe COVID-19 patients recovered from the disease and were released within 3 to 5 days after using a new treatment developed by Tel Aviv’s Sourasky Medical Center.
By MAAYAN JAFFE-HOFFMAN
Twenty-nine out of 30 moderate-to-severe COVID-19 patients who were administered a treatment developed by Tel Aviv’s Sourasky Medical Center (Ichilov Hospital) as part of a Phase I trial recovered from the disease and were released within three to five days, the hospital said Friday.
The 30th patient also recovered but it took longer.
Prof. Nadir Arber – Photo: Ichilov Hospital
The patients were given Prof. Continue Reading »
This study conducted at the Tel Aviv University has proven that 99.9% of the COVID-19 virus can be killed cheaply and within 30 seconds by using UV light-emitting diodes (UV-LEDs) at specific frequencies.
By MAAYAN JAFFE-HOFFMAN
Ultraviolet radiation is a common method of killing bacteria and viruses. Now, researchers from Tel Aviv University have proven that the novel coronavirus, SARS-CoV-2, can be killed efficiently, quickly and cheaply using ultraviolet (UV) light-emitting diodes (UV-LEDs) at specific frequencies.
“We discovered that it is quite simple to kill the coronavirus using LED bulbs that radiate ultraviolet light,” said Prof. Hadas Mamane, head of the Environmental Engineering Program at Tel Aviv University’s School of Mechanical Engineering, who led the study with Prof. Continue Reading »
Israeli Defense Ministry spokesperson reported that researchers at the Israel Institute for Biological Research identified two antiviral drugs as an effective treatment for COVID-19.
– One, an FDA-approved drug and the second, already in the advanced stages of the approval process.
By Arutz Sheva Staff
As part of the wide-ranging efforts of the Israel Institute for Biological Research to identify antiviral drugs for COVID-19, scientists have tested an analogue of the FDA-approved Cerdelga drug, and an analogue of a second drug that is currently in advanced stages of the approval process, an Israeli Defense Ministry spokesperson said Tuesday.
Treatment of a new disease such as COVID-19 using an existing, approved drug may serve as an effective short-term solution considering that one of the major challenges in addressing such a pandemic is the length of time it takes for both the research and approval phases of new drugs. Continue Reading »
REPORT: NGO Monitor found that the UN & World Health Organization facilitated millions of dollars of emergency COVID-19 funding from Canada, the EU, France, Germany, Ireland, Norway, Sweden and the UK to Palestinian organizations with links to terrorism.
By LAHAV HARKOV
Millions of dollars of international funding for the Palestinians’ coronavirus emergency response, coordinated by the World Health Organization and UN Office for the Coordination of Humanitarian Affairs (OCHA) have gone to organizations with links to terrorism, a new report by NGO Monitor found.
The research institution focused on the funding of non-governmental organizations found that several of the groups funded by OCHA and the WHO are tied to the People’s Front for the Liberation of Palestine (PFLP), which is recognized as a terrorist organization in Israel, the EU, US and Canada, and had staff members arrested and indicted late last year for the murder of 17-year-old Israeli Rina Schnerb. Continue Reading »
Prof. Dror Harats, the head of research at Sheba Medical Center at Tel Hashomer says the union with the U.S. National Institute of Health will expedite efforts that “lead to a vaccine and saving lives.”
By Maytal Yasur Beit-Or
Israel’s Chaim Sheba Medical Center at Tel Hashomer will be teaming up with the US National Institute of Health (NIH) to find a vaccine for coronavirus.
According to the plan, Sheba will send the NIH’s Vaccine Research Center samples of blood, plasma, and the virus itself taken from corona patients examined in Israel, as well as all relevant information the hospital collects during the clinical studies it runs itself and in conjunction with international pharmaceutical companies. Continue Reading »
According to a statement by Israel’s Defense Ministry, the Israel Institute for Biological Research “is the first institution to achieve a scientific breakthrough that meets all three” of the parameters needed.
– Collaborating with the town of Yeroham, a planned vaccine production facility will ensure Israeli self-sufficiency for both regular routine vaccinations and in cases of a pandemic.
By MAAYAN JAFFE-HOFFMAN, ANNA AHRONHEIM, IDAN ZONSHINE
The Israel Institute for Biological Research (IIBR) has completed a groundbreaking scientific development, identifying an antibody that neutralizes the coronavirus, SARS-CoV-2, according to a statement by the Defense Ministry.
“I am proud of the Biological Institute staff, who have made a major breakthrough,” said Defense Minister Naftali Bennett on Monday after visiting the Ness Ziona-based lab. Continue Reading »
The Israeli masks, with sizes to fit adults, kids or men with full beards, are made of high-density cotton which can be disinfected in a 60° C laundry cycle for almost unlimited reuse, as global demand has made single-use masks scarce, or too overpriced.
Israel is heading off shortages of disposable surgical masks during the coronavirus crisis by mass-producing washable versions sized to fit everyone from children to bearded men who shun shaving due to their religion.
As part of stepped-up precautions against the virus, Prime Minister Benjamin Netanyahu’s government on Sunday made it compulsory for Israelis to cover their mouths and noses while in public. Continue Reading »
Forbes published its comprehensive study ranking how 60 countries are dealing with the coronavirus, determining Israel is the safest country in the world to be in fighting against the pandemic.
By Arutz Sheva Staff
A study published in Forbes Magazine presents a comprehensive analysis examining the steps taken in various countries around the world as part of the fight against the spread of the Corona virus.
In the study, 60 countries are ranked according to different factors, including safety, risk level, treatment efficacy, and government support for people affected by the economic impact of the virus.
Continue Reading »
A police officer mans a checkpoint at the entrance to Bnei Brak.-
According to preliminary data provided by the Haifa-based company, not only have all six of the critically ill coronavirus patients that were treated survived, but four of them showed improvement in respiratory parameters.
By MAAYAN JAFFE-HOFFMAN
Six critically ill coronavirus patients in Israel who are considered high-risk for mortality have been treated with Pluristem’s placenta-based cell-therapy product and survived, according to preliminary data provided by the Haifa-based company.
The patients were treated at three different Israeli medical centers for one week under the country’s compassionate use program and were suffering from acute respiratory failure and inflammatory complications associated with COVID-19. Continue Reading »
To divert attention from their gross mismanagement, Hamas launched a rocket into Israel, then, for personal political gain, the PA Prime Minister falsely accused the IDF of purposely infecting Palestinian civilians with the coronavirus. All that as Israel transferred millions of shekels, tons of medicines and truckloads of equipment to fight the COVID-19 pandemic.
By Israel Kasnett, JNS & Israel Hayom Staff
In just the last month alone, Israel transferred millions of shekels to the Palestinian Authority and has facilitated the entry of thousands of Palestinian workers into Israel so they can work. It has expedited the transfer of equipment to the Gaza Strip to help fight the COVID-19 pandemic there. Continue Reading »
With the U.S. Food and Drug Administration’s approval for phase two trials, researchers are hoping that the Israeli drug Aviptadil, will be able to eliminate the so-called Acute Respiratory Distress Syndrome (ARDS), the condition responsible for the deaths of about 50% of all COVID-19 patients.
The U.S. Food and Drug Administration on Sunday has cleared NeuroRx, a US-Israeli pharmaceutical company, and Relief Therapeutics, a Swiss drug development company, for phase two trials for a drug that could take on a deadly condition associated with COVID-19.
The two companies announced that the FDA issued a “study may proceed” letter — which does not amount to a full-fledged drug approval — for the substance to be tried on COVID-19 patients. Continue Reading »